Neurogenic inflammation is markedly potentiated in airways that are infected with respiratory syncytial virus (RSV). Aims of this study were to determine whether this potentiation persists after the virus is cleared, investigate the mechanism of postviral potentiation, and define whether prophylaxis with a MAb against the RSV fusion protein (palivizumab) prevents this effect. Thirty days after inoculation, no evidence of active RSV infection was found in the airway epithelium by plaque assay or immunostaining and no viral nucleic sequences were detected by PCR, yet capsaicin-induced plasma extravasation in the airways that were infected 30 d earlier with RSV was still significantly larger compared with pathogen-free controls. Substance P content in lung tissues and capsaicin-induced release of this peptide from sensory nerves were significantly increased at 30 d. The administration of palivizumab 24 h before virus inoculation prevented the development of abnormal neurogenic inflammatory responses. Our data suggest that the airways remain abnormally susceptible to the proinflammatory effects of sensory nerves after RSV infection is cleared, as a result of changes in sensory innervation, and that this abnormality can be prevented by passive prophylaxis against RSV. Respiratory syncytial virus (RSV) infection presents a large public health burden worldwide (1). Half of all infants become infected with RSV in the first year of life, and by 2 y of age, most children have been infected with RSV at least once. RSV is estimated to cause up to 90% of all childhood bronchiolitis and up to 40% of all pediatric pneumonias, resulting in Ͼ120,000 hospitalizations annually in the United States (2). In addition, there is growing evidence that early RSV infection is an important risk factor for the development of recurrent wheezing during the first decade of life (3). Despite intense research efforts, the mechanism by which this virus predisposes to long-term sequelae is still unclear.
Respiratory syncytial virus (RSV) infection presents a large public health burden worldwide (1) . Half of all infants become infected with RSV in the first year of life, and by 2 y of age, most children have been infected with RSV at least once. RSV is estimated to cause up to 90% of all childhood bronchiolitis and up to 40% of all pediatric pneumonias, resulting in Ͼ120,000 hospitalizations annually in the United States (2) . In addition, there is growing evidence that early RSV infection is an important risk factor for the development of recurrent wheezing during the first decade of life (3) . Despite intense research efforts, the mechanism by which this virus predisposes to long-term sequelae is still unclear.
In previous studies, we have shown that during an acute RSV infection the airways become abnormally susceptible to the proinflammatory effects of the neurotransmitter substance P (SP) released from sensory nerves, as a result of up-regulation of the high-affinity SP [neurokinin 1 (NK1)] receptor (4) . This effect can be prevented by the administration of a MAb against the RSV fusion protein (palivizumab; MedImmune, Inc., Gaithersburg, MD, U.S.A.), given either before inoculation or during the early phase of the infection (5) . However, for linking the acute viral infection with the development of long-term changes, it is essential to establish that the inflammatory changes persist after the virus is cleared from the airways.
In the present study, we first analyzed lung tissues obtained from rats 5 d or 30 d after inoculation of RSV to establish whether evidence of persistent viral infection can be found after resolution of the acute phase. Then we investigated whether the increased neurogenic plasma extravasation ob-described above was gently deposited in each nostril using a pipette. Control rats were dosed with the same volume of virus-free medium.
RSV titration. Viral titration from lung tissues was performed at 5 and 30 d after inoculation of RSV suspension from the same stock aliquot. The lungs were homogenized in 10 mL of MEM containing 5% fetal bovine serum, and the supernatant obtained by centrifugation at 1500 ϫ g for 15 min at 4°C was stored at Ϫ70°C. Titration was carried out by standard plaque assay in HEp-2 cells, and results were expressed in plaque-forming units (pfu)/mL. Titration of the viral stock used for inoculation yielded 3.2 ϫ 10 7 pfu/mL. RSV antigens detection. Immunoperoxidase staining for RSV detection and hematoxylin/eosin staining for histopathologic analysis were performed on formalin-fixed 3 m-thick lung sections. As described previously (4, 5, 8) , sections for RSV detection were incubated with a 1:400 dilution of a pool of MAb composed of four clones specific for the matrix (M2) protein, phosphoprotein (P), fusion (F) protein, and nuclear (N) protein of human RSV (Vector Laboratories, Burlingame, CA, U.S.A.). This technique has been shown to maximize the sensitivity of RSV detection (9) . Localization of the primary antibodies was delineated with the streptavidin-biotin peroxidase complex method using an immunostaining kit (DAKO) and developed with the 3,3'-diaminobenzidine tetrahydrochloride chromogen. With this technique, cells expressing target antigens are stained with a dark-brown precipitate lining the cell membrane and cytoplasm. All slides were coded and were interpreted by a pathologist, who did not know whether the section corresponded to an RSV-inoculated or to a mediuminoculated animal.
Detection of RSV nucleic acid. The presence of RSV RNA in lung tissues was detected by reverse transcription-PCR (RT-PCR) in frozen lung tissue specimens shipped in dry ice to the University of British Columbia (Vancouver, BC, Canada; R.G.H.), based on previously published work (10) . Total RNA was extracted from homogenates of the upper and lower lobes of the right lung using RNEasy Midi-Kits (Qiagen GmbH, Hilden, Germany) according to the manufacturer's instructions. Positive controls consisted of RNA extracted from human RSV strain A Long specimens (ATCC), whereas RNA extracted from cultures of uninfected HEp-2 cells served as a negative control. RNA samples (50 Ϯ 2 g of total RNA; median Ϯ SEM) underwent reverse transcription in duplicate at 37°C for 1 h in a 50-L reaction mixture consisting of 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 5 mM MgCl 2 , 50 M each of deoxynucleotide triphosphates (dNTPs), 50 units of RNase inhibitor (Pharmacia, Mississauga, Ontario, Canada), 5 g of random hexamers (Pharmacia), and 250 units of cloned Moloney murine leukemia virus reverse transcriptase (GIBCO BRL). Heating the reaction mixture at 95°C for 5 min inactivated reverse transcriptase activity. Five microliters of the cDNA product from the reverse transcription reaction was used in a 50-L PCR reaction mixture that consisted of 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 2.5 mM MgCl 2 , 50 M each of dNTPs, 1.5 units of Taq DNA polymerase (GIBCO BRL), and 50 pmol each of primers flanking a 410-nucleotide sequence of the human RSV nucleocapsid gene (antisense 658 5'-GCGATGTCTAGGTTA-GGAAGAA-3', sense 5'-GCTTCCTTGGGTAGT-AAGCCT-3'; University of Calgary, Calgary, AB, Canada). These primers were designed on the basis of results of a Genbank search that showed a lack of homology between the sequences of these oligonucleotides to published sequences from other microorganisms or primates. Samples underwent denaturation at 94°C for 4 min, followed by 35 cycles of amplification in a thermal Robocycler-40 (Stratagene, La Jolla, CA, U.S.A.); each cycle consisted of denaturation at 94°C for 1 min, annealing at 55°C for 1 min, and extension at 72°C for 1.5 min (8 min for last cycle). After amplification, the PCR products underwent electrophoresis on ethidium bromide-stained 1.5% agarose gels and were visualized under UV light.
After Southern transfer onto Hybond-N nylon membranes (Amersham, Arlington Heights, IL, U.S.A.) and cross-linking under UV light, PCR products were hybridized with an oligonucleotide probe (5'-TAGCTCCAGAATAGTAAGCCT-3') that was end-labeled with (␥-32 P) ATP using the T4 polynucleotide kinase reaction (GIBCO BRL) following the manufacturer's instructions. Hybridization was carried out in a hybridization oven (Hybaid, Colchester, UK) at 65°C for 18 h in a solution consisting of 6ϫ SSC [0.9 M NaCl, 0.09 M sodium citrate [pH 7.0)], 5ϫ Denhardt's solution (0.1% Ficoll 400, 0.1% BSA fraction V, 0.1% polyvinylpyrrolidone), 0.5% SDS, and 100 g/mL fragmented salmon sperm DNA. After hybridization, membranes were washed in 6ϫ SSC three times for 5 min at room temperature and 30 min at 65°C and exposed to Kodak x-ray film (Eastman Kodak, Rochester, NY, U.S.A.) for up to 72 h.
For quality assurance, PCR experiments were performed in duplicate to achieve concordance of results. For ensuring that the RNA nucleic acid extraction procedure yielded specimens that did not contain PCR inhibitors, specimens underwent RT-PCR for a 445-nucleotide sequence of the constitutively expressed "housekeeping" gene glycerol-3-phosphate dehydrogenase (GAPDH), using flanking oligonucleotide primers (antisense 5'-CCCATCACCATCTTCCAG-3', sense 5'-ATGACCTTGCCCACAGCC-3') and internal probe (5'-TCACCACCATGGAGAAGG-3'). A PCR result was considered positive when an unequivocal band of predicted size was seen on autoradiographs from both replicates of each sample in the presence of predicted results for known positive and negative cell culture control specimens.
Albumin extravasation. Rats were re-anesthetized with pentobarbital sodium (50 mg/kg i.p.). Evans blue dye (30 mg/kg i.v. over 5 s) was injected into the femoral vein to measure the extravasation of albumin from airway blood vessels (11) . Immediately after the injection of the tracer, sensory nerves in the respiratory tract were stimulated with a 2-min i.v. infusion of 75 g/kg capsaicin (8-methyl-N-vanillyl-6-nonenamide; Sigma Chemical Co., St. Louis, MO, U.S.A.) dissolved in a vehicle with a final concentration of 0.75% ethanol, 0.375% Tween 80, and 0.85% NaCl in aqueous solution (12) . In a separate experiment, plasma extravasation was elicited with the injection of exogenous SP (1 g/kg over 20 s; Sigma Chemical Co.). These threshold concentrations of capsaicin and SP have little effect on airway vascular permeability in pathogen-free rats, whereas they cause large plasma extravasation during the acute phase of RSV infection, i.e. 5 d after inoculation of the virus (4). All drugs used for these experiments were delivered in a volume of 1 mL/kg body weight.
Five minutes after the injection of the tracer, the chest was opened, a cannula was inserted into the ascending aorta through the left ventricle, and the circulation was perfused for 2 min with PBS using a syringe pump set at the rate of 50 mL/min. The extrapulmonary airways (from the first tracheal ring to the end of the main stem bronchi) and the left lung were dissected and prepared for Evans blue extraction. The specimens free of connective tissue and opened along the ventral midline were blotted with bibulous paper, weighed, and incubated in 1 mL of formamide (Sigma Chemical Co.) at 50°C for 18 h to extract the extravasated Evans blue dye.
The extravasation of Evans blue-labeled albumin from the tracheobronchial microcirculation was quantified by measuring the optical density of the formamide extracts at 620-nm wavelength. The quantity of Evans blue dye extravasated in the airway tissues, expressed in nanogram per milligram of wet tissue weight, was interpolated from a standard curve of Evans blue concentrations (0.5-10 g/mL).
Bronchoalveolar lavage. We performed bronchoalveolar lavage (BAL) by infusing 28 mL/kg PBS via a tracheal cannula under pentobarbital anesthesia. The lavage fluid was instilled and withdrawn three times, and the recovery efficiency ranged between 75 and 85% for each of the animals. PCR amplification of the rat SP (NK1) receptor was performed using the following primer sequences: sense 5'-CATCAACCCAGATCTCTACC-3' targeting bases 1371-1391 and antisense 5'-GCTGGAGCTTTCTGTCATGGA-3' targeting bases 1735-1755. The housekeeping gene GAPDH was amplified simultaneously as an internal standard using the following primer sequences: sense 5'-TGAAGGTCGGTGT-CAACGGATTTGGC-3' targeting bases 35-60 and antisense 5'-CATGTAGGCCATGAGGTCCACCAC-3' targeting bases 994 -1017. As a positive control, we used the full-length rat SP (NK1) receptor cDNA (13) . Amplification was initiated with 10-min denaturation at 94°C for 1 cycle followed by 35 cycles 659 POST-RSV AIRWAY INFLAMMATION at 94°C for 45 s, 55°C for 45 s, and 72°C for 60 s using a thermal cycler (GeneAmp PCR System 9600, Perkin-Elmer). After the last cycle of amplification, the samples were incubated for 10 min at 72°C. RNA concentrations and PCR cycler were titrated to establish standard curves to document linearity and to permit semiquantitative analysis of signal strength. Amplified PCR products were separated by electrophoresis through 2% agarose gel at 45 V for 120 min. The cDNA bands were visualized by UV illumination after staining the gels with 0.5 mg/mL ethidium bromide dissolved in Tris Borate-EDTA buffer [89 mM Tris, 89 mM boric acid, 2.5 mM EDTA (pH 8.2)]. The gels were photographed, and the films were scanned and analyzed with a computerized densitometer.
SP immunoassay. SP concentration in lung tissues homogenates and BAL fluid samples was measured using a commercial kit (Cayman Chemicals, Ann Arbor, MI, U.S.A.). In brief, 100 mg of tissue from each lung sample was homogenized on ice in 1 mL of lysis buffer containing 0.1% trifluoroacetic acid, 10 M phosphoramidon, 10 M captopril, 2 M aprotinin, and 1 M pepstatin. After centrifugation at 9000 ϫ g for 30 min at 4°C, the samples were diluted in 4% acetic acid and SP was purified by solid-phase extraction through octadecyl C18 columns (Amprep; Amersham Life Science, Little Chalfont, England). The samples were evaporated to dryness and reconstituted with buffer for analysis.
This enzyme-linked immunoassay is based on the competition between unlabeled SP and a fixed quantity of SPacetylcholinesterase conjugate for a limited number of binding sites on an SP-specific antiserum. The intensity of the color change generated by the acetylcholinesterase read at 405-nm wavelength is inversely proportional to the concentration of free SP in the sample. SP standards and test samples were assayed in duplicate, and each sample was measured at two dilutions (50 L of sample/well and 25 L of sample ϩ 25 L of additional buffer/well). SP concentration measured from lung samples was normalized to wet weight. With the use of this assay, SP can be identified with 100% specificity and with a lower detection limit of 17.2 pg/mL.
Experimental protocols. For exploring the time course of RSV infection in the respiratory tract of F-344 rats, groups of rats that were inoculated with either RSV or virus-free medium were killed 5 or 30 d after inoculation and the lungs were processed for virus titration by plaque assay, immunohistochemical identification of RSV antigens, and histopathologic analysis. We also confirmed by RT-PCR the absence of RSV nucleic acid in the lungs of rats that were killed 30 d after RSV inoculation (n ϭ 5 rats).
For determining whether the increased neurogenic inflammatory responses persisted after resolution of the acute viral infection, rats were killed 30 d after inoculation, with RSV (n ϭ 11 rats) or with virus-free medium (n ϭ 12 rats). Capsaicin was injected into five of the RSV-infected rats and six of the pathogen-free rats to stimulate sensory nerves in the airway mucosa (12) . The other RSV-infected and pathogen-free rats received an injection of the vehicle used to dissolve the capsaicin. For determining whether the mechanism of post-RSV neurogenic inflammation was operating at a presynaptic or at a postsynaptic level, a group of RSV-infected rats and a group of pathogen-free controls (n ϭ 5 rats each) received an i.v. injection of exogenous SP 30 d after inoculation.
For assessing whether a MAb specific for the viral F protein is protective against post-RSV neurogenic inflammation, groups of rats were treated 24 h before the inoculation of RSV with a s.c. injection of palivizumab (MedImmune; 15 mg/kg in 0.9% NaCl; n ϭ 6 rats) or its vehicle (0.9% NaCl; 1 mL/kg; n ϭ 5 rats). A control group of three rats was injected with vehicle 24 h before intranasal administration of virus-free medium. A group of five rats that were treated with palivizumab 5 d after inoculation was compared with three control rats that received an injection 5 d postinoculation with the same volume of vehicle to assess the therapeutic effect of the MAb during established infection. The dose of palivizumab used in these studies corresponds to the dose currently used in routine clinical practice on the basis of previous studies conducted in animal models (14, 15) .
To determine whether the up-regulation of the NK1 receptor gene expression demonstrated during RSV infection (4, 8) persists after resolution of the acute infection, we compared the levels of mRNA extracted from the right lung of RSV-infected and pathogen-free rats killed 30 d after inoculation (n ϭ 5-6 per group).
For determining whether RSV infection causes acute and/or chronic changes in the expression of SP in lung tissues, SP concentration was measured in the lungs from rats 5 and 30 d after inoculation with RSV or virus-free medium using a highly sensitive and specific immunoassay. In addition, SP concentration in BAL fluid with or without stimulation of sensory nerves with capsaicin was measured in rats that were inoculated with RSV 30 d before.
Statistical analysis. Data are expressed as the mean Ϯ SEM. The effects of RSV on mean values of Evans blue extravasation and SP concentration were analyzed by two-factor ANOVA (16) . Multiple comparisons between means were performed with the Fisher protected least significant difference test (17) . Data obtained by densitometry analysis of RT-PCR products were compared with the unpaired t test. Statistical analysis was performed using the software StatView version 5.0.1 (SAS Institute, Cary, NC, U.S.A.). Differences that had a p Ͻ 0.05 were considered significant.
RESULTS

RSV infection.
Titration by plaque assay of RSV recovered from the lungs of rats that were inoculated 5 d earlier revealed the presence of replicating virus in each animal, with an average titer of 3 ϫ 10 2 pfu/mL ( Table 1) . Titration of the viral stock used for inoculation yielded 3.2 ϫ 10 7 pfu/mL. No evidence of replicating virus was found in the lungs of any of the rats that were killed 30 d after the inoculation of RSV. Immunoperoxidase staining with specific MAb performed on lung sections from F-344 rats that were killed 5 d after the inoculation of RSV revealed the presence of RSV antigens on the membrane and in the cytoplasm of bronchiolar epithelial cells. No virus was detected in the bronchioles of rats that were killed 30 d after the inoculation of RSV. Also, no virus was detected in the airways of rats 5 and 30 d after administration 660 of virus-free medium. RT-PCR amplification did not detect RSV genomic sequences in the lung tissues of any of the five animals tested.
The histopathologic changes caused by the acute RSV infection consisted predominantly of lymphomononuclear cellular infiltration in the interstitium and peribronchial areas, with only sparse polymorphonuclear leukocytes (Fig. 1) . No inflammatory cells were present after 30 d in the lung interstitium of the RSV-inoculated or control rats.
Neurogenic inflammation. After injection of the vehicle of capsaicin ( Fig. 2A, left columns) , the extravasation of Evans blue-labeled albumin in rats that were previously infected with RSV was not significantly different from controls that were kept pathogen-free, both in the extrapulmonary airways (p Ͼ 0.05) and in the intrapulmonary airways (p Ͼ 0.05).
After pharmacologic stimulation of sensory nerves with capsaicin, Evans blue extravasation in the extrapulmonary airways increased significantly (p Ͻ 0.001; Fig. 2A , top, center columns) and in rats that were previously infected with RSV was approximately twice that measured in pathogen-free controls that received an injection of the same dose of capsaicin (p Ͻ 0.001). In contrast, capsaicin had no significant effect on vascular permeability in the intrapulmonary airways ( Fig. 2A , bottom, center columns) of either previously infected rats (p Ͼ 0.05) or pathogen-free rats (p Ͼ 0.05).
The intravascular injection of exogenous SP caused a small, nonsignificant increase of Evans blue extravasation in the extrapulmonary airways of previously infected rats compared with pathogen-free controls (p Ͼ 0.05), and no increase was measured in the intrapulmonary airways as well ( Fig. 2A, right  columns) .
Capsaicin-induced Evans blue extravasation measured in the extrapulmonary airways 30 d after the infection was inhibited by pretreatment with palivizumab 24 h before inoculation (p Ͻ 0.001; Fig. 2B ). Treatment with palivizumab 5 d after RSV inoculation did not have any effect on neurogenic plasma extravasation measured 30 d after inoculation (97.7 Ϯ 7.9 versus 104.3 Ϯ 14.2; p Ͼ 0.05). Average body weight measured at the end of the experiment, i.e. 30 d after the inoculation, was still significantly lower (Ϫ9%) after RSV infection (270 Ϯ 5 g) than in pathogen-free controls (297 Ϯ 1 g; p Ͻ 0.05), but this difference was smaller (Ϫ4%) for rats that were pretreated with palivizumab before the RSV infection (285 Ϯ 7 g; p Ͼ 0.05).
SP/SP receptor expression. Semiquantitative RT-PCR analysis of lung tissues from rats that were inoculated with RSV did not show significant changes in SP (NK1) receptor mRNA expression after resolution of the RSV infection (Fig. 3) . After normalization of the densitometry measurements to the internal standard encoding the housekeeping gene GAPDH, the level of SP (NK1) receptor mRNA in the lungs of rats that had been infected with RSV 30 d earlier was 43% higher than in controls that were kept pathogen-free, but this difference was not statistically significant (p Ͼ 0.05). Enzyme-linked immunoassay revealed a large increase in SP concentration in the lungs of rats during and after infection with RSV. Five days postinoculation (Fig. 4, left columns) , SP concentration in the lung tissues of RSV-infected rats was 3.4-fold higher than in pathogen-free controls (p Ͻ 0.001). Thirty days postinoculation (Fig. 4, right columns) , this difference was still significant, although its magnitude had decreased to 2.6-fold (p Ͻ 0.05).
In the absence of nerve stimulation (Fig. 5, left columns) , SP concentration measured in BAL samples obtained 30 d after inoculation was 1.4-fold higher in rats post-RSV infection than in controls that were kept pathogen-free (p Ͻ 0.01). After stimulation of sensory nerves with capsaicin (Fig. 5, right columns), SP concentration in BAL increased significantly both in post-RSV rats (p Ͻ 0.001) and in controls (p Ͻ 0.001), but the concentration measured in previously infected rats was approximately twice that measured in pathogen-free controls that received an injection of the same dose of capsaicin (p Ͻ 0.001).
DISCUSSION
The results of this study indicate that the potentiation of neurogenic-mediated inflammatory reactions caused by lower respiratory tract infection with RSV is still present after resolution of the infection, as manifested by the exaggerated increase of microvascular permeability in response to sensory Total RNA was reverse-transcribed to cDNA, amplified by PCR using primers specific for GAPDH and for the SP (NK1) receptor, and analyzed by electrophoresis on an ethidium bromide-stained agarose gel. Densitometry analysis revealed a small increase in SP (NK1) receptor mRNA from the lungs of RSV-infected rats compared with pathogen-free controls, which was not statistically significant. This potentiation is not only qualitatively but also quantitatively similar to the response measured during the acute phase of the infection (4, 8) . The surprising observation that the vascular response to exogenous SP is no longer potentiated 30 d after the infection, combined with the lack of significant difference in expression of the high-affinity SP receptor, indicates that the mechanism of postinfectious potentiation of neurogenic inflammation operates predominantly at the presynaptic level with minor involvement of the postsynaptic component active during the acute phase of the infection (4).
The presence of RSV in the lower respiratory tract 5 d after inoculation was confirmed by titration of replicating virus and by immunohistochemical localization of specific viral antigens in the bronchiolar epithelium. However, viral antigens were not detected 30 d after RSV inoculation, despite that a strong potentiation of neurogenic-mediated inflammation was still present. In addition, 30 d after inoculation, neither replicating virus nor viral genome sequences could be detected in the lung tissues using the standard plaque assay and RT-PCR, respectively. Finally, the cellular infiltration in response to the acute infection had resolved by 30 d, and the lung tissue architecture seemed completely normal. These observations suggest that the influence of RSV on the regulatory elements of the neurogenic inflammatory pathway persists after the virus is cleared from the respiratory tract.
This study also shows that the time course of RSV infection in F-344 rats resembles the typical course in humans, in contrast to other animal models that are unable to clear this virus even after several months (18) . Thus, our model is particularly useful to study the long-term physiologic abnormalities after a mild and transient lower respiratory tract infection with RSV.
Post-RSV potentiation of neurogenic-mediated inflammation in the respiratory tract was prevented by passive prophylaxis with a MAb against the RSV fusion protein, which prevents spreading of the infection to the lower respiratory tract. No inhibition of neurogenic inflammation was found when palivizumab was given after inoculation of the virus. These findings suggest that protection against early RSV lower respiratory tract infection by passive prophylaxis may also protect against the chronic sequelae of this infection and particularly reduce the incidence of postbronchiolitis childhood asthma (19, 20) . This hypothesis is supported by a recent report based on the retrospective analysis of children protected with polyclonal RSV immune globulin (21) and is also being tested in an ongoing clinical trial involving the more potent MAb palivizumab (22) .
An interesting incidental finding was that the difference in weight between RSV-infected rats and pathogen-free controls noted during the acute phase of the infection (8) was still significant 30 d after the infection. This suggests that RSV may have persistent extrapulmonary sequelae, possibly related to the release of locally generated inflammatory mediators into the systemic circulation. Palivizumab had a partial protective effect against post-RSV weight loss, although this protective effect was not found at 5 d postinoculation (8) , suggesting that mediators released during infection of the upper airways (which is not inhibited by palivizumab) promote weight loss during the acute phase, whereas other mechanisms activated by infection of the lower respiratory tract contribute to a persistent deficit. Our findings also suggest that RSV infection, particularly with severe lower respiratory tract involvement, may affect child growth more profoundly than currently thought, and this may warrant further clinical investigation.
Mechanisms of post-RSV potentiation of neurogenic inflammation. Previous work has shown that the potentiation of neurogenic-mediated inflammation seen in the respiratory tract during the acute phase of RSV infection is primarily postsynaptic (4) and derives from up-regulation of the high-affinity SP receptor (NK1 subtype) (4, 8) . Down-regulation of the regulatory enzyme neutral endopeptidase seen in airways infected with other common viral pathogens (e.g. parainfluenza, influenza) (23) does not occur with RSV (4); therefore, the effects of this virus cannot be explained with decreased catabolism of SP released from sensory nerve fibers.
In the present study, we show that although the expression of this receptor remains slightly increased after resolution of the acute infection, it is unlikely to be the primary mechanism responsible for the postinfection changes in neurogenic inflammation. Rather, the persistence of abnormal inflammatory responses seems to depend on a presynaptic mechanism and specifically derives from structural and/or functional remodeling of the sensory innervation serving the airways, which results in a larger SP content (as a result of increased peptide synthesis and/or increased number of peptide-containing nerve fibers) and the release of larger amounts of SP after nociceptive nerve stimulation. The small SP increase in the BAL of unstimulated rats postinfection may reflect increased expression of this peptide in nonneural cells (e.g. macrophages) and/or be the effect of sensory nerves stimulation by the BAL itself. Increased expression of SP has also been shown in nonnociceptive vagal afferent neurons of guinea pigs infected with parainfluenza virus (24) . Thus, the experimental evidence supporting a presynaptic mechanism for the postviral potentiation of neurogenic inflammation is 3-fold: 1) lack of significant vascular response at 30 d postinoculation of RSV to the same dose of SP that caused large exudation 5 d postinoculation, 2) lack of persistent elevation of mRNA encoding the SP The finding of increased SP levels at 30 d is important because a previous study using a murine model of RSV infection found increased levels of SP in the BAL only during the acute phase of the infection, i.e. peaking at 4 d after primary infection, but returning to baseline by day 6 (25) . However, this study did not analyze SP expression in lung tissues, measure SP expression at later time points, or explore the release of SP from C-type nerve fibers. Our study shows that SP expression is increased in lung tissues both during and after the infection and that large amounts of this peptide are released upon sensory nerves stimulation even after resolution of the infection. Of course, some of the differences between our data and the data obtained in the murine model may also derive from the different species involved.
The changes in sensory innervation reported in this article may be linked to the potent up-regulation of the expression of nerve growth factor (NGF) and its high-affinity (trkA) and low-affinity (p75) receptors recently demonstrated in RSVinfected airways (26) . NGF (27) is a key regulatory element of neuronal development and responsiveness (28) , controls the expression of genes encoding the precursors of SP and other peptide neurotransmitters in sensory neurons (29) , and amplifies the release of neurotransmitters from nerve terminals via increased expression and function of vanilloid receptors (30) . In addition, NGF acutely up-regulates SP (NK1) receptor mRNA expression, and selective inhibition of this neurotrophin inhibits RSV-induced up-regulation of SP (NK1) receptor mRNA expression as well as the neurogenic inflammatory changes in virus-infected airways (26) . On the basis of the results of the present study, we propose that RSV, via the overexpression of NGF, activates a dual mechanism to potentiate neurogenic inflammatory responses, with a short-term predominantly postsynaptic component deriving from upregulation of the SP receptor and a longer-term predominantly presynaptic component deriving from remodeling of sensory innervation. This sequential activation/deactivation of different mechanisms may result from counterregulatory events that affect differentially the pre-and postsynaptic effects of NGF. However, additional studies are necessary to verify this hypothesis and complete the exploration of this complex system.
CONCLUSIONS
This study shows that RSV causes a persistent increase in the susceptibility of the respiratory tract to the proinflammatory effects of sensory nerves, which is still present after the acute phase of the infection resolves as manifested by the exaggerated increase in vascular permeability observed 30 d after inoculation of the virus. The marked increase in the expression of SP (NK1) receptor mRNA found in the lungs of acutely infected rats declines after resolution of the infection, suggesting that a different mechanism is involved in the chronic phase of post-RSV airway inflammation. On the basis of the data presented in this study, we propose that the sensory innervation in the airways undergoes remodeling after an acute RSV infection, resulting in increased supply and/or responsiveness of SP-releasing nerves. Our data also show that preventing the spreading of the infection to the lower respiratory tract by passive prophylaxis may inhibit postinfectious changes in the neurogenic inflammatory pathway. Although multiple neural and immunoinflammatory mechanisms are involved in the complex defense system protecting the respiratory tract against viruses, the potentiation of neurogenic-mediated inflammation in response to RSV infection may represent an important component of the pulmonary inflammatory reaction to this virus observed in humans. If so, then pharmacologic inhibition of this inflammatory pathway via modulation of neuropeptide receptors expression or specific prophylaxis against the virus may minimize the acute response to RSV and perhaps influence the development of airway hyperresponsiveness observed in a large proportion of children with a history of RSV bronchiolitis.
